The Enterprise Value as of September 2024 (TTM) for Vor Biopharma Inc. (VOR) is 27.51M

According to Vor Biopharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 27.51M. This represents a change of -75.91% compared to the average of 114.18M of the last 4 quarters.

Vor Biopharma Inc. (VOR) Historical Enterprise Value (quarterly & annually)

How has VOR Enterprise Value performed in the past?

The mean historical Enterprise Value of Vor Biopharma Inc. over the last ten years is 615.55M. The current 27.51M Enterprise Value has changed 346.93% with respect to the historical average. Over the past ten years (40 quarters), VOR's Enterprise Value was at its highest in in the December 2020 quarter at 804.65M. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Vor Biopharma Inc. (VOR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Vor Biopharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vor Biopharma Inc. (VOR) Average Enterprise Value

How has VOR Enterprise Value performed in the past?

The current Enterprise Value of Vor Biopharma Inc. (VOR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Vor Biopharma Inc. (VOR) Enterprise Value vs. Peers

How is VOR’s Enterprise Value compared to its peers?

Vor Biopharma Inc.’s Enterprise Value is less than Gracell Biotechnologies Inc. (5.46B), less than Theseus Pharmaceuticals, Inc. (138.26M), less than Monte Rosa Therapeutics, Inc. (279.81M), less than Design Therapeutics, Inc. (271.25M), less than Erasca, Inc. (660.88M), less than Edgewise Therapeutics, Inc. (1.53B), less than Talaris Therapeutics, Inc. (50.00M), greater than Adicet Bio, Inc. (-82159510.00), less than Cullinan Oncology, Inc. (866.65M), less than Nuvalent, Inc. (7.08B), less than Ventyx Biosciences, Inc. (131.47M), less than Arcellx, Inc. (4.09B), less than Kiniksa Pharmaceuticals, Ltd. (1.70B), less than Bolt Biotherapeutics, Inc. (37.21M), less than Day One Biopharmaceuticals, Inc. (969.04M), greater than Lyra Therapeutics, Inc. (23.07M), less than Autolus Therapeutics plc (640.59M), less than Foghorn Therapeutics Inc. (417.08M), less than Shattuck Labs, Inc. (118.76M), less than Kymera Therapeutics, Inc. (3.12B), less than Nurix Therapeutics, Inc. (1.55B),

Build a custom stock screener for Vor Biopharma Inc. (VOR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vor Biopharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vor Biopharma Inc. (VOR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vor Biopharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.